Up a level |
Walker, Harry E, Rizzo, Manfredi, Fras, Zlatko, Jug, Borut, Banach, Maciej and Penson, Peter E ORCID: 0000-0001-6763-1489
(2021)
CRISPR Gene Editing in Lipid Disorders and Atherosclerosis: Mechanisms and Opportunities.
METABOLITES, 11 (12).
857-.
Sahebkar, Amirhossein, Serban, Maria-Corina, Penson, Peter ORCID: 0000-0001-6763-1489, Gurban, Camelia, Ursoniu, Sorin, Toth, Peter P, Jones, Steven R, Lippi, Giuseppe, Kotani, Kazuhiko, Kostner, Karam et al (show 3 more authors)
(2017)
The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis.
DRUGS, 77 (11).
pp. 1187-1197.
Rizzo, Manfredi, Colletti, Alessandro, Penson, Peter E ORCID: 0000-0001-6763-1489, Katsiki, Niki, Mikhailidis, Dimitri P, Toth, Peter P, Gouni-Berthold, Ioanna, Mancini, John, Marais, David, Moriarty, Patrick et al (show 5 more authors)
(2023)
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP).
PHARMACOLOGICAL RESEARCH, 189.
106679-.
Banach, Maciej, Surma, Stanislaw, Reiner, Zeljko, Katsiki, Niki, Penson, Peter E ORCID: 0000-0001-6763-1489, Fras, Zlatko, Sahebkar, Amirhossein, Paneni, Francesco, Rizzo, Manfredi and Kastelein, John
(2022)
Personalized management of dyslipidemias in patients with diabetes-it is time for a new approach (2022).
CARDIOVASCULAR DIABETOLOGY, 21 (1).
263-.
Banach, Maciej, Katsiki, Niki, Latkovskis, Gustavs, Rizzo, Manfredi, Pella, Daniel, Penson, Peter E ORCID: 0000-0001-6763-1489, Reiner, Zeljko and Cicero, Arrigo FG
(2021)
Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia.
ARCHIVES OF MEDICAL SCIENCE, 17 (4).
pp. 856-863.
Penson, Peter E ORCID: 0000-0001-6763-1489, Bruckert, Eric, Marais, David, Reiner, Zeljko, Pirro, Matteo, Sahebkar, Amirhossein, Bajraktari, Gani, Mirrakhimov, Erkin, Rizzo, Manfredi, Mikhailidis, Dimitri P et al (show 12 more authors)
(2022)
Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from <i>the International Lipid Expert Panel</i> (ILEP).
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 13 (3).
pp. 1596-1622.